Are safety and adverse event profile appears similar between early trials in both Anti PD-1 and Anti PD-L1

Are safety and adverse event profile appears similar between early trials in both Anti PD-1 and Anti PD-L1

AnnualMeeting2016

3 years
222 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Petros Grivas, MD of Cleveland Clinic asked the question Are safety and adverse event profile appears similar between early trials in both Anti PD-1 and Anti PD-L1
Up Next Autoplay